Free Trial

Curaleaf (OTCMKTS:CURLF) Shares Up 8.2% - Still a Buy?

Curaleaf logo with Medical background

Key Points

  • Curaleaf Holdings, Inc. (OTCMKTS:CURLF) saw its stock price increase by 8.2% to $1.54 during trading, despite an 81% decline in daily trading volume.
  • The company's recent earnings report showed a loss of ($0.07) per share, in line with analyst expectations, with a forecast of -0.25 earnings per share for the current year.
  • Curaleaf operates primarily in the cannabis sector, offering a range of products including flower, concentrates, and edibles across its domestic and international segments.
  • MarketBeat previews top five stocks to own in September.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s stock price rose 8.2% during trading on Monday . The company traded as high as $1.62 and last traded at $1.54. Approximately 119,050 shares traded hands during trading, a decline of 81% from the average daily volume of 630,615 shares. The stock had previously closed at $1.42.

Curaleaf Stock Up 1.9%

The firm has a market capitalization of $972.15 million, a PE ratio of -4.68 and a beta of 0.68. The company has a debt-to-equity ratio of 1.08, a current ratio of 1.41 and a quick ratio of 0.70. The company has a 50-day moving average price of $0.98 and a 200 day moving average price of $1.04.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.07) earnings per share for the quarter, hitting the consensus estimate of ($0.07). Curaleaf had a negative return on equity of 14.12% and a negative net margin of 17.37%. Analysts forecast that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

About Curaleaf

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines